Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571.

Kumar S, Mishra N, Raina D, Saxena S, Kufe D. Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571. Mol Pharmacol. 2003 Feb; 63(2):276-82.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.